Repro-Endo: Female Repro Flashcards
1
Q
Mechanism of Leuprolide?
A
- Leuprolide and Goserelin
- GnRH anolog
- Pulsatile –> Agonist
- Continous –>Antagonist
- -> Downregulates GnRH in Pituitary
- -> Decrease LH and FSH
2
Q
Clinical Use of Leuprolide?
A
- Pulsatile –> Infertility
- Continous –> w/ Flutamide for 1 wk Testosterone surge.
- Prostate cancer
- Uterine Fibroids
- Endometriosis
- Polycystic Ovary Syndrome
- Precocious puberty
3
Q
SEs Leuprolide?
A
- Antiandrogen
- Nausea
- Vomiting
- Headache (Light-headedness)
- Hypoestrogenic state
- Hot flashes
- Vaginal dryness
- Bone density loss
4
Q
Mechanism of Estrogens?
A
- Binds to Estrogen Receptors
- Stimulates Endometrial Growth
- Reduces LDL, Raises HDL
- Steroidal: Ethinyl Estradiol and Mestranol
- Nonsteroidal: Diethylstilbestrol (DES)
-
Natural: Premarin-conjugated estrogens
- Soy Isoflavones, Red clover, Black cohosh, Vit. E
5
Q
Clinical use of Estrogen?
A
Females:
- Birth Control
- Cycle regulation
- Hypogonadism
- Ovarian failure
- Menstraul abnormalities
- Hormone Replacement Therapy - post menopausal w/out a History of Breast Cancer
- Men: Androgen-dependent Prostate cancer
6
Q
SEs Estrogens?
A
- Estrogen w/out Progesterone –> Endometrial cancer
- DES –> Clear Cell Adenocarcinoma
-
Bleeding in the Postmenopausal women
- Increased Risk of Thrombi (Hypercoagulable)
-
Contraindicated:
- ER+ Breast cancer and History of DVTs
- Uncontrolled HTN
- Migraines w/ Aura
- Smokers > 35 y.om (microthrombi risk)
7
Q
(3) Selective Estrogen Receptor Modulators (SERMs)?
A
- Clomiphene
- Tamoxifen
- Raloxifene
8
Q
Mechanism of Clomiphene?
A
- Estrogen receptors Antagonist in Hypothalamus
- Prevents normal feedback inhibition
- -> Increased GnRH
- -> Increased Release of LH and FSH from Pituitary
- -> Stimulates ovulation (Increased)
9
Q
Clinical use of Clomiphene?
A
- Infertility due to Anovulation
- PCOS
- Fertility
10
Q
SEs of Clomiphene?
A
- Hot flashes - Temp. Control w/in Hypothalamus
- Ovarian enlargment
- Multiple simultaneous pregnancies
- Visual Disturbances (Blurring, Diplopia)
- GI and Breast Discomfort (tenderness)
11
Q
Mechanism of Tamoxifen?
A
- Partial Estrogen receptor Agonist/Antagonist (SERM)
- Upregulates TGF-β
-
Must be activated by CYP2D6
- SSRIs (Fluoxetine) inhibit CYP2D6 - contraindicated
- Antagonist - Breast tissue
-
Agonist - Uterus (Endometrial Tissue) and Bone
- A/w Endometrial cancer
- A/w Thomboemboitic events
12
Q
Clinical use of Tamoxifen?
A
- Post-Menopausal (50+) women
- Hormone Replacement Therapy (HRT) w/ Family History
- ER+ Breast cancer
- Progesterone-resistant Endometrial and Ovarian cancer
- Melanoma
- Osteoporosis
- Discontinue after 5 years: acts as an Agonist in Breast
13
Q
Mechanims of Raloxifene?
A
- SERM
- Antagonist - Breast and Uterus (Endometrium)
-
Agonist - Bone
- Increased risk of Thromboembolic events
- Decreased Resportpion of bone
- ER+ Breast Cancer w/ History of Endometrial cancer
- Osteoporosis
- SE: Hot flashes, Sweating/warmth, Increased Vaginal Discharge, Joint/Muscle pain, Increased Thromboembolism
14
Q
Hormone Replacement Therapy (HRT)?
A
- Relief or Prevention of Menopausal symptoms
- Hot flashes, Vaginal atrophy
- Osteoporosis (Increased Estrogen, Decreased Osteoclast activity)
- Unopposed Estrogen Replacement Therapy (ERT)
- Incrased Risk of Endometrial cancer so Progesterone is added
- Increased Cardiovascular risk in Older women /w Higher doses
15
Q
Anastrozole (Letrozole) / Exemestane?
A
- Aromatase Inhibitors used in Postmenopausal women w/ Breast cancer
- Better than Aminoglutethimid, no effect on Mineralocorticoid or Glucocorticoid synthesis
- Continue to be effective beyond 5 years
- No Risk of Endometrial cancer or Thromboemboilic events
16
Q
Mechanism of Progestins?
A
- Megestrol, Medroxyprogesterone
- Bind Progesterone receptors
- Decrease growth
-
Increased Weight gain
- Anorexia-cachaexia related to Cancer and AIDS
- Increase Vascularization of Endometrium
- -> Stimulates Endometrial glandular secretions
- -> Spiral artery development
- -> Suppresses ovulation
17
Q
Clinical use of Progestins?
A
- Birth Contorl and Ovulation suppresion
- Menstrual cycle control
- Stabilization of Endometrium
- Uterine control and Protection
- Stimulate appetitie in Cachectic patients
18
Q
Mechanism of Mifepristone (RU-486)?
A
- Competitive inhibitor of Progestins at Progesterone Receptors
- -> Lose Progesterone –> Lose Endometrial layer
- -> Lose Pregnancy